A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-024-09113-x ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Valeria Mercadante und 20 weiteren Autor:innen. Beteiligte Einrichtung: Eastman Dental Institute, University College London, London, England. v.mercadante@ucl.ac.uk. Hauptthemen laut MEDLINE: Xerostomia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This systematic review aimed to assess the updated literature for the prevention of salivary gland hypofunction and xerostomia induced by non-surgical cancer therapies.
Methods
Electronic databases of MEDLINE/PubMed, EMBASE, and Cochrane Library were searched for randomized controlled trials (RCT) that investigated interventions to prevent salivary gland hypofunction and/or xerostomia. Literature search began from the 2010 systematic review publications from the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) up to February 2024. Two independent reviewers extracted information regarding study design, study population, cancer treatment modality, interventions, outcome measures, methods, results, risk of bias (RoB version 2), and conclusions for each article.
Results
A total of 51 publications addressing preventive interventions were included. Eight RCTs on tissue-sparing radiation modalities were included showing significant lower prevalence of xerostomia, with unclear effect on salivary gland hypofunction. Three RCTs on preventive acupuncture showed reduced prevalence of xerostomia but not of salivary gland hypofunction. Two RCTs on muscarinic agonist stimulation with bethanechol suggested a preventive effect on saliva flow rate and xerostomia in patients undergoing head and neck radiation or radioactive iodine therapy. Two studies on submandibular gland transfer showed higher salivary flow rates compared to pilocarpine and lower prevalence of xerostomia compared to no active intervention. There is insufficient evidence on the effectiveness of vitamin E, amifostine, photobiomodulation, and miscellaneous preventive interventions.
Conclusion
This systematic review continues to support the potential of tissue-sparing tecniques and intensity-modulated radiation therapy (IMRT) to preserve salivary gland function in patients with head and neck cancer, with limited evidence on other preventive strategies, including acupuncture and bethanecol. Preventive focus should be on optimized and new approaches developed to further reduce radiation dose to the parotid, the submandibular, and minor salivary glands. As these glands are major contributors to moistening of the oral cavity, limiting the radiation dose to the salivary glands through various modalities has demonstrated reduction in prevalence and severity of salivary gland hypofunction and xerostomia. There remains no evidence on preventive approaches for checkpoint inhibitors and other biologicals due to the lack of RCTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eastman Dental Institute, University College London, London, England. v.mercadante@ucl.ac.uk.
- Vanderbilt University, Nashville, TN, USA.
- Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
- Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa, Israel.
- Department of Oral Medicine, University of Zagreb School of Dental Medicine, Zagreb, Croatia.
- Department of Oral Medicine/Oral & Maxillofacial Surgery, Atrium Health Carolinas Medical Center, Charlotte, NC, USA.
Zitieren
APA
Mercadante, V., Smith, D. K., Abdalla-Aslan, R., Andabak-Rogulj, A., Brennan, M. T., Jaguar, G. C., Clark, H., Fregnani, E. R., Gueiros, L. A., Hovan, A., Kurup, S., Laheij, A. M. G. A., Lynggaard, C. D., Napeñas, J. J., Peterson, D. E., Elad, S., Van Leeuwen, S., Vissink, A., Wu, J., …, & Jensen, S. B. (2025). A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-09113-x
Vancouver
Mercadante V, Smith DK, Abdalla-Aslan R, Andabak-Rogulj A, Brennan MT, Jaguar GC, et al. A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies. Supportive Care in Cancer. 2025. doi:10.1007/s00520-024-09113-x
BibTeX
@article{Mercadante2025,
author = {Mercadante, Valeria and Smith, Derek K and Abdalla-Aslan, Ragda and Andabak-Rogulj, Ana and Brennan, Michael T and Jaguar, Graziella Chagas and Clark, Haley and Fregnani, Eduardo Rodrigues and Gueiros, Luiz Alcino and Hovan, Allan and Kurup, Seema and Laheij, Alexa M G A and Lynggaard, Charlotte Duch and Napeñas, Joel J and Peterson, Douglas E and Elad, Sharon and Van Leeuwen, Stephanie and Vissink, Arjan and Wu, Jonn and Saunders, Deborah P and Jensen, Siri Beier},
title = {A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-024-09113-x}
}
EUVIMED